https://www.selleckchem.com/pr....oducts/nvp-tae226.ht
s on the NSQ and negative nasal examination findings. Findings from this analysis indicate that there was no evidence of adverse effect on either olfactory or nasal health measures with repeated intermittent administration of esketamine nasal spray at any dose over the course of short-term (4 weeks) or long-term (16-100 weeks) studies. TRANSFORM-1 NCT02417064, date of registration 15/04/2015; TRANSFORM-2 NCT02418585, date of registration 16/04/2015; TRANSFORM-3 NCT02422186, date of registration 21/04/2015; SUSTAIN-1 NCT02493868, date
Like
Comment
Share
